What's Going On With ImmunityBio Shares Wednesday?
What's Going On With ImmunityBio Shares Wednesday?
The offering is expected to close on or about Dec. 12.ImmunityBio, Inc. (NASDAQ:IBRX) shares are trading lower on Wednesday after the company announced the pricing of its offering of 33,333,334 shares at $3.00 each.
ImmunityBio, Inc. (納斯達克:IBRX)的股票週三交易下跌，此前該公司宣佈以每股3.00美元的價格發行33,333,334股。
The company plans to use the net proceeds from this offering to advance the commercialization of ANKTIVA for treating certain types of bladder cancer, fund trials for bladder cancer and non-small cell lung cancer, support further research and development, meet working capital needs and for other general corporate purposes.
該公司計劃利用本次發行的淨收益推進ANKTIVA在治療某些類型膀胱癌的商業化，資助膀胱癌和非小細胞肺癌的試驗，支持進一步的研發，滿足運營資金需求及其他一般企業用途。
In addition, the company has granted the underwriters a 30-day option to purchase up to 5,000,000 additional shares of common stock at the public offering price.
此外，公司已授予承銷商一個爲期30天的選擇權，購買最多5,000,000股額外普通股，價格爲公開發行價格。
The offering is expected to close on or about Dec. 12.
該發行預計將在12月12日左右結束。
IBRX Price Action: At the time of writing, ImmunityBio stock is trading 2.9% lower at $3.11, according to data from Benzinga Pro.
IBRX價格動態：根據Benzinga Pro的數據，截至撰寫時，ImmunityBio的股價下跌2.9%，爲3.11美元。
Image: Akava Photo from Pixabay
圖片：來自Pixabay的Akava Photo
譯文內容由第三人軟體翻譯。